InvestorsHub Logo
Followers 8
Posts 1894
Boards Moderated 0
Alias Born 05/05/2016

Re: TC43 post# 7383

Friday, 10/20/2017 9:13:32 AM

Friday, October 20, 2017 9:13:32 AM

Post# of 44784

For the critics, I think that it is really hard to judge the leadership as a failure. The stem cell market is unchartered territory and there have surely been mistakes along the way. However, they are pioneers and there isn't any textbook on how to stand up a game changing company in unknown territory.

Well stated, and it is the salient point!

For the cheerleaders. Great technology, product, and I agree on the doorstep of advancement. Don't be so celebratory and naive around management though. Zami was an excellent visionary and strategist to go after the 3D technology and placental source, but the naysayers do have some good points about bringing in industry experience and more business horse power. Management does matter!

Yes it does!!! But it's the visionary who is the sine que non,
the rest is just accountants and MBA's.

The only quibble I have is this "cheerleader" stuff. I think of myself
as an investor, who thinks Pluristem is a great opportunity. The obvious
manifestation of that is that I genuinely like the company and do say so.

Thanks for a nicely stated perspective!